Hydralazine Hydrochloride
NDC 68475-514, Hydralazine Hydrochloride, injection, from Navinta LLC.
- Product NDC
- 68475-514
- Status
- Listed
- Labeler
- Navinta LLC
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202938
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68475-514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE20 mg/mL
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68475-514-02 | 68475051402 | 25 VIAL in 1 PACKAGE (68475-514-02) / 1 mL in 1 VIAL (68475-514-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ae5d85df-11a3-4952-ade2-596d57cdd987
Use it
Look up 68475-514 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68475-514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68475-514. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.